Abandoned Compound definition

Abandoned Compound shall have the meaning set forth in Section 3.1.
Sample 1Sample 2Sample 3
Abandoned Compound shall have the meaning given in Section 4.1.
Sample 1Sample 2Sample 3
Abandoned Compound means any (a) Abandoned Candidate/Development Compound (as defined in Section 9.1(c)) or (b) Abandoned Research/Lead Compound (as defined in Section 9.1(c)).
Sample 1Sample 2Sample 3

Examples of Abandoned Compound in a sentence

  • If after Enanta followed the procedure set forth in Section 11.2.2 for asserting a breach of contract and Xxxxxx does not cure its breach for failure to use Commercially Reasonable Efforts to Develop a Candidate or Commercialize a Product in any Major Market Country, then Enanta shall have the right, in its sole discretion upon ten (10) days written notice to Xxxxxx, to designate such Candidate or Product as a Abandoned Compound.

  • Finally, a TPM that originally only protected access may come to prevent copying as well, if the decrypting software or device it is keyed to becomes obsolete: for example, a TPM protecting a work that requires a particular software program in order to be unlocked and read may need to be circumvented in order to be accessed for the purposes of copying once that software becomes obsolete and ceases to be available.

  • Should the Parties fail to reach a mutually agreeable set of terms, ISIS will be free to license the Abandoned Compound to a Third Party on terms no more favorable to such Third Party than those last offered by ZENECA, or to continue on its own to develop and commercialize the Abandoned Compound.

  • This subsection (g) shall survive expiration or termination of the Research Term as to each Abandoned Compound for a period of time lasting through the completion of [**] for such Abandoned Compound and thereafter shall terminate and be of no further force or effect as to such Abandoned Compound.

  • The QCP shall demonstrate how the SP ensures quality performance during the contract period of performance.

  • If Icagen so licenses a third party in accordance with the prior four sentences, Section 6.5 shall remain in effect as to the Abandoned Compound.

  • All other forms and attachments that are governed locally by unit directives may be utilized and maintained for a local function but shall not be placed in the inmate’s master file.

  • Failure of ZENECA to develop a Development Candidate or commercialize a Collaborative Product pursuant to Paragraph 3.1 will be deemed to constitute discontinuation of * CONFIDENTIAL TREATMENT REQUESTED development or commercialization and the Development Candidate or Collaboration Product will become an Abandoned Compound with or without notice to ISIS hereunder.

  • If ZENECA has incorporated into the Abandoned Compound significant proprietary ZENECA technology or Third Party technology which it may sublicense to ISIS (including, but not limited to, specialized formulation or delivery technology) the Parties will negotiate in good faith an additional royalty for access to such technology, if required.

  • In any event, Seller shall not exercise its right to designate such Relevant Product as an Abandoned Compound pursuant to Section 11.3.6 of the License Agreement except with the prior written consent of the Required Royalty Parties (such consent not to be unreasonably withheld, delayed or conditioned).


More Definitions of Abandoned Compound

Abandoned Compound or "ABANDONED COMPOUND SERIES" means a Compound or Compound Series identified by the research performed under this Agreement which: (i) has been selected in writing by a Party as suitable for further development but which the other Party has declined in writing to develop further; or (ii) which has been abandoned in writing by one or both Parties pursuant to Section 3.2.7.
Sample 1Sample 2Sample 3
Abandoned Compound means a Development Candidate which ZENECA subsequently ceases to develop or commercialize pursuant to Paragraph 3.1(b) or 3.
Sample 1Sample 2
Abandoned Compound shall have the meaning as such term is defined in Clause 2.
Sample 1Sample 2
Abandoned Compound means a Development Candidate which ZENECA subsequently ceases to develop or commercialize pursuant to Paragraph 3.1(b) or 3.3.
Sample 1Sample 2

Related to Abandoned Compound

  • Licensed Compound means [***].

  • Licensed Compounds means: (a) Research Program Active Compounds; (b) Novartis Active Compounds; (c) salts, hydrates, solvates, esters, metabolites, intermediates, stereoisomers and polymorphs of Research Program Active Compounds or Novartis Active Compounds; and (d) prodrugs of Research Program Active Compounds or Novartis Active Compounds (any of the foregoing, a “Licensed Compound”).

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Back-Up Compound means, with reference to any particular Development Candidate or Drug Product Candidate, a Compound which (a) has the same principal mode of action (i.e., Potentiator or Corrector) as that Development Candidate or Drug Product Candidate; and (b) was among the group of Compounds, identified by VERTEX as potential additional lead molecules having the same principal mode of action, from which the Development Candidate was selected.

  • Lead Compound means any compound of lead other than galena which, when treated in the manner described below, yields to an aqueous solution of hydrochloric acid a quantity soluble lead compound exceeding, when calculated as lead monoxide, five percent of the dry weight of the portion taken analysis.

  • Product Candidate means any pharmaceutical product developed, manufactured and/or tested by or on behalf of the Company that has not received a Regulatory Authorization for commercial distribution other than in connection with pre-clinical or clinical trials.

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • Development Candidate means a Compound that meets the Development Candidate Criteria for the initiation of a Development Program for the treatment of CF, and which is the subject of a notice from Vertex to CFFT that Vertex intends to commence formal pre-clinical development of the Compound in the Field pursuant to the provisions of Section 3.1 hereof.

  • Covered Product The consumer product that You purchased concurrently with and is covered by this Agreement.

  • Exempt compound means the same as defined in Rule 2.

  • Hemp product means the same as that term is defined in § 3.2-4112.

  • Collaboration IP means Collaboration Know-How and Collaboration Patents.

  • Compound means the taking of two or more ingredients and fabricating them into a single

  • Commercialized shall have corresponding meanings.

  • Edible cannabis product means cannabis product that is intended to be used, in whole or in part, for human consumption, including, but not limited to, chewing gum, but excluding products set forth in Division 15 (commencing with Section 32501) of the Food and Agricultural Code. An edible cannabis product is not considered food, as defined by Section 109935 of the Health and Safety Code, or a drug, as defined by Section 109925 of the Health and Safety Code.

  • Biosimilar Product means, with respect to a Licensed Product and on a country-by-country basis, a product that [***].

  • Biological product means a virus, therapeutic serum, toxin, antitoxin, vaccine, blood, blood component or derivative, allergenic product, protein other than a chemically synthesized polypeptide, or analogous product, or arsphenamine or any derivative of arsphenamine or any other trivalent organic arsenic compound, applicable to the prevention, treatment, or cure of a disease or condition of human beings.

  • Antibody means a molecule comprising or containing one or more immunoglobulin variable domains or any fragments, derivatives, variants or modifications thereof that bind to the same antigen.

  • Collaboration Patent Rights means Patent Rights claiming Collaboration Know-How.

  • Compounds means any or all of the following chemicals, as the context requires:

  • Biological Samples means any physical samples obtained from Study Participants in accordance with the Protocol for the purposes of the Study.

  • Terminated Product has the meaning set forth in Section 11.3.1.

  • Product Technology means the Product Know-How and Product Patents.

  • Diagnostic Product means any test or assay for diagnosing or detecting a disease, disorder, medical condition, or symptom.

  • Licensed Product means a product or part of a product in the Licensed Field of Use: (A) the making, using, importing or selling of which, absent this license, infringes, induces infringement, or contributes to infringement of a Licensed Patent; or (B) which is made with, uses or incorporates any Technology.